Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Endometrial Neoplasms 8 Lymphatic Metastasis 5 Melanoma 4 Stomach Neoplasms 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Uterine Neoplasms 1 Solitary Pulmonary Nodule 1 Skull Base Neoplasms 1 Secondary Lymphedema 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Micrometastasis 1 Multiple Pulmonary Nodules 1 Mixed Tumor, Mesodermal 1 Lymphedema 1 Liver Neoplasms 1 Invasive Breast Cancer 1 Inflammatory Breast Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Diseases 1 Esophageal Neoplasms 1 Digestive System Diseases 1 Cervical Cancer Stage IB1 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Indocyanine Green × Clear all

NCT02920216 2022-03-31

SALVADS-Fluo

Institut de Cancérologie de Lorraine

Phase NA Completed

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡